Suppr超能文献

在20种人类肿瘤细胞系中分析了纤溶酶原激活剂、纤溶酶原激活剂抑制剂和促凝剂。

Plasminogen activators, plasminogen activator inhibitors and procoagulant analyzed in twenty human tumor cell lines.

作者信息

Cajot J F, Kruithof E K, Schleuning W D, Sordat B, Bachmann F

出版信息

Int J Cancer. 1986 Nov 15;38(5):719-27. doi: 10.1002/ijc.2910380516.

Abstract

We have analyzed the CM of 20 human tumor cell lines for the presence of PA, PA-I and PC. Most of the cell lines expressed PA activity as measured by a radioiodinated fibrin plate assay. The urinary type and tissue-type PA activities were specifically quantified by means of purified inhibitory antibodies. U-PA and/or t-PA antigen, as measured by radioimmunoassays, were detected in all but 4 of the CM and were generally 10 times more concentrated than PA activity, indicating the presence of specific PA-Is. Analysis of CM by electrophoresis followed by fibrin-agarose zymography demonstrated the presence not only of free but also of inhibitor-complexed PA. Affinity purification demonstrated that 8/20 cell lines expressed detectable PA-I activity. The PA-I1 and PA-I2 inhibitors were most frequently observed, while PN was recovered only from CM of the HT1080 fibrosarcoma cell line. PC activity, as measured by the plasma recalcification time method, was found in 9/20 CM. It was of the thromboplastin tissue factor type since most of its activity was lost when assayed with a Factor VII-deficient plasma.

摘要

我们分析了20种人类肿瘤细胞系的条件培养基(CM)中纤溶酶原激活物(PA)、纤溶酶原激活物抑制剂I(PA-I)和纤溶酶原(PC)的存在情况。通过放射性碘化纤维蛋白平板试验测定,大多数细胞系表达PA活性。利用纯化的抑制性抗体特异性地定量了尿激酶型和组织型PA活性。通过放射免疫测定法检测,除4种条件培养基外,其他所有条件培养基中均检测到尿激酶型纤溶酶原激活物(U-PA)和/或组织型纤溶酶原激活物(t-PA)抗原,其浓度通常比PA活性高10倍,表明存在特异性PA抑制物。通过电泳分析条件培养基,随后进行纤维蛋白-琼脂糖酶谱分析,结果表明不仅存在游离的PA,还存在与抑制剂结合的PA。亲和纯化表明,20种细胞系中有8种表达可检测到的PA-I活性。最常观察到PA-I1和PA-I2抑制剂,而仅从HT1080纤维肉瘤细胞系的条件培养基中回收了纤溶酶原激活物抑制剂神经氨酸酶(PN)。通过血浆复钙时间法测定,在20种条件培养基中有9种检测到PC活性。它属于组织凝血活酶组织因子类型,因为在用缺乏因子VII的血浆进行测定时,其大部分活性丧失。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验